The Multifaceted Effects of Agmatine on Functional Recovery after Spinal Cord Injury through Modulations of BMP-2/4/7 Expressions in Neurons and Glial Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Park, Yu Mi ^a   Lee, Won Taek ^a   Bokara, Kiran Kumar ^a   Seo, Su Kyoung ^a   Park, Seung Hwa ^b   Kim, Jae Hwan ^a   Yenari, Midori A ^c   Park, Kyung Ah ^a   Lee, Jong Eun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLADDER FUNCTION; CELL LOSS; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; DRUG ACTIVITY; GLIA CELL; LOCOMOTION; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; REMYELINIZATION; SCAR FORMATION; SPINAL CORD INJURY; VERTEBRA;

AGMATINE; ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED ICR; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MOTOR ACTIVITY; MYELIN SHEATH; NEUROGLIA; NEURONS; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

MUS;

EID: 84872657724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053911     Document Type: Article

References (83)

1. Guertin PA, (2008) Anxiolytics may promote locomotor function recovery in spinal cord injury patients. Neuropsychiatr Dis Treat 4: 759-763.
2. Yoshimura N, (1999) Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 57: 583-606.
3. Rasouli A, Bhatia N, Dinh P, Cahill K, Suryadevara S, et al. (2009) Resection of glial scar following spinal cord injury. J Orthop Res 27: 931-936.
4. McDonald JW, Belegu V, (2006) Demyelination and remyelination after spinal cord injury. J Neurotrauma 23: 345-359.
5. Kotter MR, Stadelmann C, Hartung HP, (2011) Enhancing remyelination in disease-can we wrap it up? Brain 134: 1882-1900.
6. Kulbatski I, Mothe AJ, Keating A, Hakamata Y, Kobayashi E, et al. (2007) Oligodendrocytes and radial glia derived from adult rat spinal cord progenitors: morphological and immunocytochemical characterization. J Histochem Cytochem 55: 209-222.
7. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, et al. (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
8. Piletz JE, Chikkala DN, Ernsberger P, (1995) Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 272: 581-587.
9. Murayama T, Tsai SC, Adamik R, Moss J, Vaughan M, (1993) Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity. Biochemistry 32: 561-566.
10. Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, et al. (2000) Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 97: 10584-10589.
11. Chen D, Zhao M, Mundy GR, (2004) Bone morphogenetic proteins. Growth Factors 22: 233-241.
12. Karimi-Abdolrezaee S, Schut D, Wang J, Fehlings MG, (2012) Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS One 7: e37589.
13. Obermair FJ, Schroter A, Thallmair M, (2008) Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology (Bethesda) 23: 296-304.
14. Reiriz J, Espejo M, Ventura F, Ambrosio S, Alberch J, (1999) Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J Neurobiol 38: 161-170.
15. Lein PJ, Beck HN, Chandrasekaran V, Gallagher PJ, Chen HL, et al. (2002) Glia induce dendritic growth in cultured sympathetic neurons by modulating the balance between bone morphogenetic proteins (BMPs) and BMP antagonists. J Neurosci 22: 10377-10387.
16. Xiao Q, Du Y, Wu W, Yip HK, (2010) Bone morphogenetic proteins mediate cellular response and, together with Noggin, regulate astrocyte differentiation after spinal cord injury. Exp Neurol 221: 353-366.
17. de Rivero Vaccari JP, Marcillo A, Nonner D, Dietrich WD, Keane RW, (2009) Neuroprotective effects of bone morphogenetic protein 7 (BMP7) treatment after spinal cord injury. Neurosci Lett 465: 226-229.
18. Setoguchi T, Yone K, Matsuoka E, Takenouchi H, Nakashima K, et al. (2001) Traumatic injury-induced BMP7 expression in the adult rat spinal cord. Brain Res 921: 219-225.
19. Chalazonitis A, D'Autreaux F, Pham TD, Kessler JA, Gershon MD, (2011) Bone morphogenetic proteins regulate enteric gliogenesis by modulating ErbB3 signaling. Dev Biol 350: 64-79.
20. See J, Mamontov P, Ahn K, Wine-Lee L, Crenshaw EB III, et al. (2007) BMP signaling mutant mice exhibit glial cell maturation defects. Mol Cell Neurosci 35: 171-182.
21. Matsuura I, Taniguchi J, Hata K, Saeki N, Yamashita T, (2008) BMP inhibition enhances axonal growth and functional recovery after spinal cord injury. J Neurochem 105: 1471-1479.
22. Setoguchi T, Nakashima K, Takizawa T, Yanagisawa M, Ochiai W, et al. (2004) Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Exp Neurol 189: 33-44.
23. Kim JH, Lee YW, Park YM, Park KA, Park SH, et al. (2011) Agmatine-reduced collagen scar area accompanied with surface righting reflex recovery after complete transection spinal cord injury. Spine (Phila Pa 1976) 36: 2130-2138.
24. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, et al. (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23: 635-659.
25. Pajoohesh-Ganji A, Byrnes KR, Fatemi G, Faden AI, (2010) A combined scoring method to assess behavioral recovery after mouse spinal cord injury. Neurosci Res 67: 117-125.
26. Sharp KG, Dickson AR, Marchenko SA, Yee KM, Emery PN, et al. (2012) Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation. Exp Neurol 235: 345-356.
27. Hvid M, Jensen HK, Deleuran B, Kemp K, Andersson C, et al. (2009) Evaluation of FITC-induced atopic dermatitis-like disease in NC/Nga mice and BALB/c mice using computer-assisted stereological toolbox, a computer-aided morphometric system. Int Arch Allergy Immunol 149: 188-194.
28. de Groat WC, Yoshimura N, (2006) Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Prog Brain Res 152: 59-84.
29. Widerstrom-Noga E, Cruz-Almeida Y, Krassioukov A, (2004) Is there a relationship between chronic pain and autonomic dysreflexia in persons with cervical spinal cord injury? J Neurotrauma 21: 195-204.
30. Estores IM, (2003) The consumer's perspective and the professional literature: what do persons with spinal cord injury want? J Rehabil Res Dev 40: 93-98.
31. Anderson KD, (2004) Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 21: 1371-1383.
32. Amar AP, Levy ML, (1999) Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44: 1027-1039.
33. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS, (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3: 73-76.
34. Thuret S, Moon LD, Gage FH, (2006) Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 7: 628-643.
35. Bregman BS, Kunkel-Bagden E, Reier PJ, Dai HN, McAtee M, et al. (1993) Recovery of function after spinal cord injury: mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp Neurol 123: 3-16.
36. Nygren LG, Fuxe K, Jonsson G, Olson L, (1974) Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5, 6-dihydroxytryptamine induced degeneration. Brain Res 78: 377-394.
37. Shoichet MS (2008) Strategies for Regeneration and Repair in the Injured Central Neurous System. Taylor & Francis Group, LLC.CRC press. 221 p.
38. Boido M, Garbossa D, Vercelli A, (2011) Early graft of neural precursors in spinal cord compression reduces glial cyst and improves function. J Neurosurg Spine 15: 97-106.
39. Barnabe-Heider F, Goritz C, Sabelstrom H, Takebayashi H, Pfrieger FW, et al. (2010) Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 7: 470-482.
40. Choi BH, (1986) Myelin-forming oligodendrocytes of developing mouse spinal cord: immunocytochemical and ultrastructural studies. J Neuropathol Exp Neurol 45: 513-524.
41. Wu J, Yoo S, Wilcock D, Lytle JM, Leung PY, et al. (2010) Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia 58: 410-422.
42. Lytle JM, Wrathall JR, (2007) Glial cell loss, proliferation and replacement in the contused murine spinal cord. Eur J Neurosci 25: 1711-1724.
43. Ille F, Atanasoski S, Falk S, Ittner LM, Marki D, et al. (2007) Wnt/BMP signal integration regulates the balance between proliferation and differentiation of neuroepithelial cells in the dorsal spinal cord. Dev Biol 304: 394-408.
44. Fuller ML, DeChant AK, Rothstein B, Caprariello A, Wang R, et al. (2007) Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 62: 288-300.
45. Gomes WA, Mehler MF, Kessler JA, (2003) Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 255: 164-177.
46. Auguet M, Viossat I, Marin JG, Chabrier PE, (1995) Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 69: 285-287.
47. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ, (1996) Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 316 (Pt 1): 247-249.
48. Halaris A, Plietz J, (2007) Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 21: 885-900.
49. Yu CG, Marcillo AE, Fairbanks CA, Wilcox GL, Yezierski RP, (2000) Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 11: 3203-3207.
50. Shunmugavel A (2010) Simvastatin protects bladder and renal functions following spinal cord injury in rats. J Inflamm (Lond).
51. Silver J, Miller JH, (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
52. Franklin RJ, Ffrench-Constant C, (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9: 839-855.
53. Jarjour AA, Zhang H, Bauer N, Ffrench-Constant C, Williams A, (2012) In vitro modeling of central nervous system myelination and remyelination. Glia 60: 1-12.
54. Wu B, Ren X, (2009) Promoting axonal myelination for improving neurological recovery in spinal cord injury. J Neurotrauma 26: 1847-1856.
55. Keirstead HS, Blakemore WF, (1997) Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol 56: 1191-1201.
56. Redwine JM, Armstrong RC, (1998) In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol 37: 413-428.
57. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD, (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20: 6404-6412.
58. Nishiyama A, (2007) Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist 13: 62-76.
59. Cigognini D, Satta A, Colleoni B, Silva D, Donega M, et al. (2011) Evaluation of early and late effects into the acute spinal cord injury of an injectable functionalized self-assembling scaffold. PLoS One 6: e19782.
60. Butt SJ, Harris-Warrick RM, Kiehn O, (2002) Firing properties of identified interneuron populations in the mammalian hindlimb central pattern generator. J Neurosci 22: 9961-9971.
61. Grillner S, Zangger P, (1979) On the central generation of locomotion in the low spinal cat. Exp Brain Res 34: 241-261.
62. Jacobs BL, Martin-Cora FJ, Fornal CA, (2002) Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev 40: 45-52.
63. Jordan LM, Liu J, Hedlund PB, Akay T, Pearson KG, (2008) Descending command systems for the initiation of locomotion in mammals. Brain Res Rev 57: 183-191.
64. Fouad K, Rank MM, Vavrek R, Murray KC, Sanelli L, et al. (2010) Locomotion after spinal cord injury depends on constitutive activity in serotonin receptors. J Neurophysiol 104: 2975-2984.
65. Saruhashi Y, Matsusue Y, Fujimiya M, (2009) The recovery of 5-HT transporter and 5-HT immunoreactivity in injured rat spinal cord. Arch Orthop Trauma Surg 129: 1279-1285.
66. Boulenguez P, Vinay L, (2009) Strategies to restore motor functions after spinal cord injury. Curr Opin Neurobiol 19: 587-600.
67. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG, (2008) Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 25: E14.
68. do Carmo Cunha J, de Freitas Azevedo Levy B, de Luca BA, de Andrade MS, Gomide VC, et al. (2007) Responses of reactive astrocytes containing S100beta protein and fibroblast growth factor-2 in the border and in the adjacent preserved tissue after a contusion injury of the spinal cord in rats: implications for wound repair and neuroregeneration. Wound Repair Regen 15: 134-146.
69. Basso DM, Beattie MS, Bresnahan JC, (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139: 244-256.
70. Hampton DW, Asher RA, Kondo T, Steeves JD, Ramer MS, et al. (2007) A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci 26: 3024-3035.
71. Tsujii M, Akeda K, Iino T, Uchida A, (2009) Are BMPs involved in normal nerve and following transection?: a pilot study. Clin Orthop Relat Res 467: 3183-3189.
72. Davies JE, Proschel C, Zhang N, Noble M, Mayer-Proschel M, et al. (2008) Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 7: 24.
73. Liu A, Niswander LA, (2005) Bone morphogenetic protein signalling and vertebrate nervous system development. Nat Rev Neurosci 6: 945-954.
74. Henriquez JP, Krull CE, Osses N, (2011) The Wnt and BMP Families of Signaling Morphogens at the Vertebrate Neuromuscular Junction. Int J Mol Sci 12: 8924-8946.
75. Pisano JM, Colon-Hastings F, Birren SJ, (2000) Postmigratory enteric and sympathetic neural precursors share common, developmentally regulated, responses to BMP2. Dev Biol 227: 1-11.
76. Nakashima K, Takizawa T, Ochiai W, Yanagisawa M, Hisatsune T, et al. (2001) BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci U S A 98: 5868-5873.
77. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, et al. (2003) Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34: 558-564.
78. Harvey BK, Hoffer BJ, Wang Y, (2005) Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol Ther 105: 113-125.
79. Reissmann E, Ernsberger U, Francis-West PH, Rueger D, Brickell PM, et al. (1996) Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 122: 2079-2088.
80. White RE, Jakeman LB, (2008) Don't fence me in: harnessing the beneficial roles of astrocytes for spinal cord repair. Restor Neurol Neurosci 26: 197-214.
81. Parikh P, Hao Y, Hosseinkhani M, Patil SB, Huntley GW, et al. (2011) Regeneration of axons in injured spinal cord by activation of bone morphogenetic protein/Smad1 signaling pathway in adult neurons. Proc Natl Acad Sci U S A 108: E99-107.
82. Finley MF, Devata S, Huettner JE, (1999) BMP-4 inhibits neural differentiation of murine embryonic stem cells. J Neurobiol 40: 271-287.
83. Gambaro K, Aberdam E, Virolle T, Aberdam D, Rouleau M, (2006) BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. Cell Death Differ 13: 1075-1087.